Meteen naar de content
USA ORDERS: Due to high demand, please allow up to 48 hours for dispatch until further notice. Thank you for your patience.
USA ORDERS: Due to high demand, please allow up to 48 hours for dispatch until further notice. Thank you for your patience.
USA ORDERS: Due to high demand, please allow up to 48 hours for dispatch until further notice. Thank you for your patience.
BioPlexPeptides.co.ukBioPlexPeptides.co.uk
0
SS-31 Peptide Research Overview | Research Studies

SS-31 Peptide Research Overview | Research Studies

SS-31 Elamipretide Research, Mitochondrial Function, Cardiolipin and Cellular Energy Studies

SS-31 is a synthetic tetrapeptide that has become an important research compound in the study of mitochondrial biology.

Also known as Elamipretide, MTP-131 and Bendavia, SS-31 belongs to the Szeto-Schiller family of peptides and is particularly notable because of its interaction with the inner mitochondrial membrane.

Unlike many larger peptides, SS-31 consists of only four amino-acid residues.

Its unusual aromatic-cationic structure has attracted substantial research attention because SS-31 can associate with mitochondrial membranes and has a strong relationship with cardiolipin, an important phospholipid concentrated within the inner mitochondrial membrane.

This has made SS-31 peptide research particularly relevant to studies investigating mitochondrial structure, cellular energy production, oxidative stress, electron transport, mitochondrial ageing and cellular responses to metabolic stress.

Rather than acting through a conventional cell-surface peptide receptor, much of the scientific interest surrounding SS-31 centres on its direct interaction with mitochondrial membrane biology.

What Is SS-31 Peptide?

SS-31 is a synthetic aromatic-cationic tetrapeptide.

Its sequence is commonly represented as:

D-Arg-Dmt-Lys-Phe-NH₂

where Dmt represents 2',6'-dimethyltyrosine.

The compound emerged from research into a family of short peptides known as Szeto-Schiller peptides.

These peptides contain alternating aromatic and positively charged residues, producing unusual physicochemical properties that allow them to interact with biological membranes.

SS-31 subsequently became one of the most extensively investigated members of this peptide family.

In scientific literature, the compound can appear under several names:

SS-31

Elamipretide

MTP-131

Bendavia

Szeto-Schiller peptide 31

These names generally refer to the same underlying tetrapeptide, although Elamipretide is particularly common within pharmaceutical and clinical-development literature.

Understanding these alternative names is important when reviewing SS-31 research because searching only for "SS-31" can miss substantial amounts of published work indexed under Elamipretide.

Why Is SS-31 Called a Mitochondrial Peptide?

SS-31 is frequently described as a mitochondria-targeting peptide because research has demonstrated its preferential interaction with mitochondrial membranes.

Mitochondria are specialised structures found within eukaryotic cells.

One of their best-known functions is the generation of adenosine triphosphate, or ATP, through oxidative phosphorylation.

ATP provides chemical energy used throughout cellular biology.

However, mitochondria perform considerably more than energy production.

They also participate in processes including cellular signalling, calcium regulation, lipid metabolism, redox biology and programmed cell death.

The inner mitochondrial membrane is particularly important because it contains the components of the electron transport chain and ATP synthase machinery required for oxidative phosphorylation.

SS-31 research has therefore focused heavily on what happens when the peptide interacts with this specialised membrane environment.

What Is Cardiolipin?

Cardiolipin is central to understanding why SS-31 is scientifically interesting.

Cardiolipin is an unusual phospholipid strongly associated with mitochondrial membranes and particularly enriched within the inner mitochondrial membrane.

Its molecular structure differs from conventional phospholipids and allows cardiolipin to play important structural and functional roles within mitochondria.

Cardiolipin contributes to organisation of the inner mitochondrial membrane and interacts with numerous proteins involved in mitochondrial energy production.

Research has shown that SS-31 associates strongly with cardiolipin-containing membranes.

This interaction is believed to contribute significantly to the peptide's mitochondrial localisation and many of the downstream effects investigated experimentally.

How Does SS-31 Interact with the Inner Mitochondrial Membrane?

The inner mitochondrial membrane contains the molecular machinery responsible for oxidative phosphorylation.

SS-31's aromatic-cationic structure allows the peptide to partition into the interfacial region of negatively charged lipid membranes.

Experimental membrane studies have demonstrated that SS-31 binding is strongly influenced by membrane surface charge.

Rather than simply inserting into the membrane and disrupting it, research indicates that SS-31 can influence lipid packing and membrane-surface electrostatics.

This is scientifically important because the organisation and physical properties of mitochondrial membranes can influence numerous mitochondrial processes.

The interaction between SS-31 and cardiolipin therefore provides researchers with an interesting model for studying how a very small synthetic peptide can influence mitochondrial membrane behaviour.

SS-31 and Mitochondrial Bioenergetics Research

Bioenergetics describes how biological systems produce, transform and use energy.

Within mitochondria, much of this research centres on oxidative phosphorylation.

Electrons move through the mitochondrial electron transport chain, creating an electrochemical proton gradient across the inner mitochondrial membrane.

ATP synthase then uses this gradient to generate ATP.

Because SS-31 associates with the inner mitochondrial membrane and cardiolipin, researchers have investigated whether the peptide can influence this highly organised bioenergetic system.

Published studies have examined SS-31 interactions with mitochondrial proteins involved in ATP production and metabolic processes.

Chemical cross-linking combined with mass spectrometry has identified SS-31-interacting proteins associated with oxidative phosphorylation and mitochondrial metabolism.

This makes mitochondrial energy research one of the central themes within the SS-31 literature.

SS-31 and the Electron Transport Chain

The mitochondrial electron transport chain consists of several large protein complexes embedded within the inner mitochondrial membrane.

Their organisation and relationship with surrounding membrane lipids are important for efficient electron transfer.

Cardiolipin contributes to the structural organisation of these respiratory complexes.

Because SS-31 interacts with cardiolipin, researchers have investigated how the peptide may influence the environment surrounding electron-transport proteins.

This is one reason descriptions of SS-31 as simply an "antioxidant peptide" can be incomplete.

Early research focused heavily on reactive oxygen species, but later mechanistic work has increasingly examined membrane organisation, cardiolipin interactions and mitochondrial bioenergetics more broadly.

SS-31 and Oxidative Stress Research

Reactive oxygen species, commonly abbreviated ROS, are chemically reactive molecules produced through normal cellular metabolism.

Mitochondria are an important source of cellular ROS.

At controlled levels, reactive oxygen species participate in cellular signalling.

Excessive or poorly regulated ROS production, however, can alter proteins, lipids and other cellular components.

SS-31 has therefore been extensively investigated in experimental models involving mitochondrial oxidative stress.

Research has examined whether interactions between SS-31, mitochondrial membranes and the electron transport system can influence mitochondrial ROS production and cellular responses to oxidative stress.

For example, laboratory studies in skeletal muscle cells have investigated SS-31 in relation to mitochondria-derived superoxide and inflammatory signalling.

These studies help explain why oxidative stress is one of the most frequently encountered topics when searching for SS-31 peptide research.

Is SS-31 Simply an Antioxidant?

Describing SS-31 solely as an antioxidant oversimplifies its research profile.

Early interpretations of Szeto-Schiller peptides placed substantial emphasis on antioxidant properties.

However, subsequent research has suggested that their biological behaviour involves more complex interactions with mitochondrial membranes and cardiolipin.

SS-31's relationship with membrane surface charge, lipid organisation, respiratory proteins and mitochondrial bioenergetics has therefore become increasingly important in mechanistic research.

Modern SS-31 research consequently tends to examine mitochondrial structure and function rather than treating the peptide simply as a molecule that directly neutralises reactive oxygen species.

SS-31 and ATP Research

ATP is the primary energy-carrying molecule used by cells.

Mitochondrial ATP generation depends on the coordinated activity of the electron transport chain, proton gradient and ATP synthase.

Because SS-31 research focuses heavily on the inner mitochondrial membrane, researchers have investigated mitochondrial ATP production and respiratory efficiency in experimental models.

The interest here is not that SS-31 somehow "contains energy".

Instead, researchers are studying whether changes in mitochondrial membrane organisation and bioenergetic function can influence the cell's ability to generate ATP efficiently.

This distinction is important when interpreting descriptions of SS-31 as a "cellular energy peptide".

The scientifically meaningful question concerns mitochondrial bioenergetics rather than a direct energy-producing action of the peptide itself.

SS-31 and Mitochondrial Structure

Mitochondria contain highly folded inner membranes known as cristae.

These folds dramatically increase the surface area available for oxidative phosphorylation.

Cristae architecture is therefore closely connected with mitochondrial function.

Cardiolipin plays an important role in maintaining mitochondrial membrane organisation and curvature.

Research into Elamipretide has consequently examined whether interactions with cardiolipin influence mitochondrial membrane structure and cristae organisation.

This area connects SS-31 research at the molecular level with broader questions surrounding mitochondrial efficiency and cellular metabolism.

SS-31 and Ageing Research

Mitochondrial function changes with age.

Researchers have investigated age-associated alterations in mitochondrial respiration, oxidative stress, membrane organisation and energy production across numerous experimental models.

Because SS-31 interacts directly with mitochondrial membrane biology, it has become a research compound of interest in this field.

Studies have investigated SS-31 in aged tissues and experimental models of age-associated mitochondrial dysfunction.

For example, research published in eLife examined mitochondrial proton leak in aged cardiomyocytes and the effects associated with SS-31 treatment in that experimental model.

This does not mean SS-31 should simply be described as an "anti-ageing peptide".

The more accurate description is that researchers use SS-31 to investigate mechanisms involving mitochondrial changes associated with ageing.

SS-31 and Cardiovascular Research

Cardiac tissue has extremely high energy requirements.

Heart muscle cells therefore contain large numbers of mitochondria.

This makes mitochondrial bioenergetics particularly relevant to cardiovascular research.

SS-31 has been investigated extensively in experimental models involving cardiac mitochondrial function, oxidative stress and energy metabolism.

The compound has also progressed beyond laboratory models into clinical research involving conditions associated with mitochondrial dysfunction.

These investigations provide additional scientific information about the compound but should be distinguished from established therapeutic use.

SS-31 and Neurological Research

The nervous system also has substantial energy requirements.

Neurons depend heavily on mitochondrial function to maintain membrane potentials, signalling and cellular homeostasis.

Consequently, mitochondrial dysfunction is studied extensively within neuroscience.

SS-31 has been investigated in neurological and neurodegenerative research models involving mitochondrial stress.

A 2026 study from researchers at Imperial College London, for example, investigated SS-31 in relation to α-synuclein membrane interactions, aggregation and mitochondrial impairment.

This demonstrates that SS-31 remains an active area of mitochondrial research rather than being solely an older experimental peptide.

SS-31 and Mitochondrial Protein Interactions

One particularly interesting area of research concerns proteins that physically interact with SS-31 within mitochondria.

Researchers using chemical cross-linking and mass spectrometry identified several mitochondrial proteins interacting with SS-31.

The identified proteins included cardiolipin-binding proteins associated with ATP production through oxidative phosphorylation and proteins involved in metabolic processes.

This supports a more complex picture of SS-31 research in which the peptide's mitochondrial behaviour involves interactions within the wider cardiolipin-protein environment of the inner mitochondrial membrane.

SS-31, Elamipretide, MTP-131 and Bendavia – Are They the Same?

These names can cause confusion when researching the compound.

SS-31 is the experimental peptide designation commonly used throughout biochemical literature.

Elamipretide became the principal development name used as the compound progressed through pharmaceutical research.

MTP-131 and Bendavia are additional development names encountered in earlier literature.

Researchers searching databases should therefore consider all of these terms.

Searching only for "SS-31 peptide" may return research-focused peptide literature, while "Elamipretide" often retrieves clinical and pharmaceutical-development studies.

Using both terms provides a more complete picture of the published research.

How Does SS-31 Differ from MOTS-c?

SS-31 and MOTS-c are both frequently discussed within mitochondrial peptide research, but they are very different compounds.

SS-31 is a synthetic four-residue aromatic-cationic peptide whose research centres heavily on cardiolipin and the inner mitochondrial membrane.

MOTS-c is a mitochondria-derived peptide encoded within mitochondrial DNA and studied in areas including metabolic signalling and cellular stress responses.

Their association with mitochondria therefore comes from different biological mechanisms.

This distinction is important because grouping all "mitochondrial peptides" together can obscure major differences in their structure and research pathways.

Why Is SS-31 Important in Mitochondrial Research?

SS-31 is unusual because it gives researchers a relatively small molecular tool for investigating mitochondrial membrane biology.

Its research connects several important areas:

mitochondrial membranes,

cardiolipin,

oxidative phosphorylation,

electron transport,

ATP production,

reactive oxygen species,

cristae organisation,

cellular energy metabolism, and mitochondrial responses to stress.

These interconnected areas explain why SS-31 has generated research interest across cellular biology, ageing research, cardiovascular science, neuroscience and mitochondrial disease research.

Has SS-31 Been Studied Clinically?

Yes.

Elamipretide has progressed into human clinical research, including studies involving disorders characterised by mitochondrial dysfunction.

One example is research involving Barth syndrome, a rare genetic condition involving abnormal cardiolipin metabolism.

A Phase 2/3 crossover study and subsequent open-label extension investigated Elamipretide in participants with genetically confirmed Barth syndrome.

Clinical investigation is important scientific context, but it should not be confused with automatically establishing SS-31 as an approved treatment for the many conditions investigated experimentally.

Laboratory research, preclinical studies and clinical trials represent different levels of evidence.

Why SS-31 Research Continues to Develop

The scientific understanding of SS-31 has changed considerably since the peptide was first investigated.

Earlier work focused strongly on mitochondrial oxidative stress.

Later research expanded the picture to include cardiolipin interactions, membrane electrostatics, mitochondrial protein interactions, respiratory-chain organisation and bioenergetic function.

Research continues to investigate SS-31 because mitochondria themselves sit at the centre of numerous areas of cellular biology.

As analytical methods become more sophisticated, researchers can examine the peptide's molecular interactions in considerably greater detail than was possible during its early development.

SS-31 as a Research Compound

For laboratory researchers, SS-31 represents a synthetic mitochondrial research peptide with a particularly well-developed scientific literature.

Its short tetrapeptide structure contrasts with many substantially larger research peptides.

Its primary scientific distinction is its relationship with mitochondrial membrane biology rather than conventional extracellular receptor signalling.

Research involving SS-31 therefore commonly focuses on mitochondrial function, cardiolipin, oxidative stress, cellular bioenergetics and the molecular organisation of the inner mitochondrial membrane.

Understanding this mechanism is essential when interpreting the expanding SS-31 and Elamipretide literature.

Conclusion

SS-31, also known as Elamipretide, MTP-131 and Bendavia, is a synthetic aromatic-cationic tetrapeptide extensively investigated in mitochondrial research.

Its scientific importance centres on its interaction with cardiolipin and the inner mitochondrial membrane.

This places SS-31 at the intersection of several major research areas, including mitochondrial bioenergetics, electron transport, ATP production, oxidative stress, membrane organisation, ageing-related mitochondrial changes and cellular responses to metabolic stress.

Research has progressed from early studies focusing largely on reactive oxygen species to increasingly detailed investigation of mitochondrial membranes, cardiolipin interactions and mitochondrial protein networks.

SS-31 has also progressed into clinical research under the name Elamipretide, further expanding the scientific literature surrounding the compound.

For researchers studying mitochondrial biology, SS-31 therefore represents an important molecular research tool for investigating how mitochondrial membrane organisation relates to cellular energy and function.

Continue Exploring...

View SS-31 10mg Mitochondrial Research Peptide ⟶

Read the MOTS-c Peptide Research Overview ⟶

View Independent Peptide Testing at BioPlex Peptides ⟶

Use the BioPlex Peptide Reconstitution Calculator ⟶

View BioPlex Research Peptides ⟶

All discussion is presented strictly for educational and scientific research purposes only, supporting informed study, data interpretation, and responsible laboratory investigation.

Reactie plaatsen

Uw e-mailadres wordt niet gepubliceerd..

Winkelwagen 0

Uw winkelwagen is momenteel leeg.

Begin met winkelen